Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Centro de Investigaciones Biológicas Margarita Salas (CIB) is a leading research center within the Spanish National Research Council (CSIC) that operates at the intersection of biology, chemistry, and medicine. While primarily a research institution, it functions as a biotech incubator and technology provider, spinning off numerous companies and licensing advanced therapeutic candidates. The center focuses on structural biology, cellular and molecular medicine, and environmental biotechnology, with a strong emphasis on neurodegenerative diseases and oncology. CIB provides a robust pipeline of early-stage drug candidates and diagnostic tools through its specialized technology platforms. Its business model involves extensive collaboration with pharmaceutical partners to translate basic research into clinical applications.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on CIB.